STING signaling is a potential immunotherapeutic target in colorectal cancer.
Chon HJ, Kim H, Noh JH, Yang H, Lee WS, Kong SJ, Lee SJ, Lee YS, Kim WR, Kim JH, Kim G, Kim C.
Chon HJ, et al. Among authors: kim h, kim g, kim c, kim wr, kim jh.
J Cancer. 2019 Aug 27;10(20):4932-4938. doi: 10.7150/jca.32806. eCollection 2019.
J Cancer. 2019.
PMID: 31598165
Free PMC article.